Article
Oncolytic Virotherapy for Cancer: Clinical Experience
13 Apr 2021
Abstract excerpt
Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the concept of oncolytic virotherapy is not new, advancements in the fields of molecular biology and virology have renewed the interest in using viruses as oncolytic agents. Backed by robust preclinical data, many oncolytic viruses have entered clinical trials....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
